KARACHI; Pharmaceuticals have been used to treat illnesses for thousands of years. The early days of medication included plants and herbal remedies to treat a variety of diseases and traumas. Today, the long and complex journey to demonstrate the safety and efficacy of a compound and bring it from the laboratory into the hands of patients in need, is a multi-billion-dollar global industry.
Pharmaceutical companies continually strive towards innovative new treatments that help people live longer and healthier lives. These therapies are developed, manufactured, marketed and distributed around the world by pharmaceutical companies every day.
Such is the new shining star in Karachi’s pharma market by the name WM Pharma- World is Mine, Mr Mumtaz Ali Shaikh CEO of the company while recalling his earlier struggle starting as Scientific Officer to Regional Manager in and around Pakistan market conceived that marketplace need to be met with appropriate marketing strategies hence understanding the urgency he commenced a partnership with market’s renowned manufacturers and started a company reaching to the deep roots of society where quality healthcare once less known.
Currently marketing a wide range of medicines for healthcare viz Antibiotics, Analgesics, Antiulcerants and a number of line extensions in the pipeline on a reasonable cost.
He observed pharmaceutical industry has greatly contributed to the increase in life expectancy for men and women across the world. It has been reported that pharmaceutical advancements accounted for 73% of the total increase in life expectancy between 2000 and 2020, across 30 developing and high-income countries.
While financial investment in novel therapies provides patients with new care options and often improved quality of care, the pharmaceutical industry also recognizes the significance of its responsibility to manage the perceived potential conflict of interest where profits rather than patients’ welfare is the priority. To maintain this balance, the industry employs leading scientific researchers and clinicians, and collaborates with outside medical experts and professional organizations from the preclinical period through introduction of the product and beyond. Industry collaboration with experts in the field works to ensure that patients have access to the most current therapy options available through physicians who support the use of these new therapies. Medical experts also help to establish the appropriate usage of new therapies by gaining clinical experience with these drugs, which also serves to protect patient safety as far as possible. During each phase of the drug development and introduction process, the pharmaceutical industry’s actions are also monitored by third parties, whose primary interest is to ensure adherence to the highest standard of quality and safety for any potential patient population. These third parties include representatives from regulatory authorities, institutional review boards, as well as patient advocacy groups, all acting as a system of checks and balances. Collaborative groups also serve to assist the pharmaceutical industry in guaranteeing a safe and streamlined drug development process. Throughout this process, collaboration across all stakeholder groups provides increased benefit to patients and physicians, delivering the highest quality of scientific advancement in the medical field.
CEO Mumtaz Shaikh Said that driving medical progress by researching, developing and bringing new medicines that improve health and quality of life for patients for our communities, the pharmaceutical industry is a key asset to the local and global economy.
He said that Consumer access to effective and affordable medicines is an imperative for public health, social equity, and economic development, but this need is not being served adequately. But WM Pharma ensures that all segments of our society are adequately met and with honor and receive quality medicines.